Login / Signup

Carbazochrome sodium sulfonate and tranexamic acid combination therapy to reduce blood transfusions after 24 h of injury: A retrospective study.

Hiroki NagasawaKazuhiko OmoriSoichirou OtaKen-Ichi MuramatsuIkuto TakeuchiHiromichi OhsakaYouichi Yanagawa
Published in: Acute medicine & surgery (2024)
In patients with trauma, treatment with CSS with TXA may reduce the requirement for blood transfusion after 24 h. Moreover, this treatment can improve admission outcomes without increasing complications.
Keyphrases
  • combination therapy
  • emergency department
  • metabolic syndrome
  • replacement therapy
  • glycemic control